Evaluation of Efficacy, Safety and Tolerability of NGM282 (aldafermin) in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (ALPINE4)

  • Roberts, Stuart (Primary Chief Investigator (PCI))
  • Jones, Alison (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date14/02/20 → 31/12/22

Keywords

  • Gastroenterology
  • Cirrhosis
  • Clinical trial